Highlights of the American College of Cardiology Annual Scientific Sessions 2017
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Recently, the 66th Annual American College of Cardiology (ACC) Scientific Sessions convened in Washington, DC, building on the theme of “more learning, less lecturing”. Despite the challenge of winter storm Stella, the meeting went off without a hitch, bringing together more than 18 500 attendees from across the world. Clinical science was at the forefront of the meeting, with 23 late-breaking clinical trials and 17 featured clinical research presentations. In addition, ACC.17 (2017 American College of Cardiology Annual Scientific Sessions) offered an updated core curriculum program, half-day intensive sessions focusing on palliative care, healthcare equity, and faculty development, live case demonstrations, and a personalized skills center, featuring hands-on simulation and test question review. Audience participation and response were featured throughout the meeting. New this year, physician attendees received simultaneous credit for continuing medical education and American Board of Internal Medicine Maintenance of Certification (ABIM-MOC) for the majority of the educational sessions; European physicians received external continuing medical education credit; and pharmacists and nurses received continuing education credits.
The opening session featured Richard Chazal, MACC, ACC President, and this year’s Simon Dack Lecturer, David Skorton, FACC, Secretary of the Smithsonian Institute. Dr Chazal remarked on the ever-changing landscape of cardiovascular medicine, while Dr Skorton emphasized the importance and richness of the arts and humanities in our profession and our lives. Thereafter, 3 late-breaking clinical trials were presented, setting the stage for an exciting display of practice-changing science. The FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated …